Shanghai Xiao Fang Pharmaceutical Co.,Ltd.

SHSE:603207 Stock Report

Market Cap: CN¥4.1b

Shanghai Xiao Fang PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 6/6

Shanghai Xiao Fang PharmaceuticalLtd has a total shareholder equity of CN¥1.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.4B and CN¥160.9M respectively. Shanghai Xiao Fang PharmaceuticalLtd's EBIT is CN¥225.6M making its interest coverage ratio -70.6. It has cash and short-term investments of CN¥852.0M.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-70.6x
CashCN¥852.01m
EquityCN¥1.19b
Total liabilitiesCN¥160.90m
Total assetsCN¥1.35b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 603207's short term assets (CN¥998.8M) exceed its short term liabilities (CN¥160.7M).

Long Term Liabilities: 603207's short term assets (CN¥998.8M) exceed its long term liabilities (CN¥181.1K).


Debt to Equity History and Analysis

Debt Level: 603207 is debt free.

Reducing Debt: 603207 has not had any debt for past 5 years.

Debt Coverage: 603207 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 603207 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies